A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 46
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ONLS
Long Form : Overall Neuropathy Limitation Scale
No. Year Title Co-occurring Abbreviation
2022 Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome. POEMS, sVEGF
2022 Patients' attitude towards vaccination after Guillain Barré syndrome. GBS, SF-36
2022 Physical and Mental Aspects of Quality of Life in Patients With Charcot-Marie-Tooth Disease Type 1A. BDI, CMT1A, CMTES, FSS, MRC, QoL
2022 The value of MUNIX as an objective electrophysiological biomarker of disease progression in chronic inflammatory demyelinating polyneuropathy. CIDP, MRC-SS, MUNIX, NCSS, R-ODS, TA
2021 Employment status of patients with Charcot-Marie-Tooth type 1A. BDI, CMT1A, CMTES, CMTNS, FES, FSS, MRC
2021 Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy. IVIG, LQI, MMN, MRC, SCIG
2021 Minimal important differences and self-identifying treatment response in chronic inflammatory demyelinating polyneuropathy. aMIDc, cI-RODS, CIDP, MDC95, MID
2021 [The application of scales and characteristics of disability in the common genotypes of Charcot-Marie-Tooth disease]. CMT, CMTES, CMTNS, FDS
2020 Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years. CIDP, IVIG, LQI, MRC, SCIG
10  2020 Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot-Marie-Tooth disease type 1A. BDI, CMT1A, CMTNS, FES, FSS, HNPP, MRC, QoL
11  2019 Comparative value and determinants of suitability of outcome measures in treated chronic inflammatory demyelinating polyneuropathy. CIDP, I-RODS, MRC-SS
12  2019 Efficacy and Safety of Octagam in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. CIDP, IVIG
13  2019 Electrophysiological determinants of the clinical severity of axonal peripheral neuropathy. NCS, PN, SNAP, SRAR
14  2019 Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins. CIDP, IVIG, MUNIX, R-ODS
15  2019 Neuropathic pain in patients with Charcot-Marie-Tooth type 1A. CMT1A, CMTNS, IASP, MRC, NeP, PDQ
16  2019 Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes. IVIg
17  2018 Chronic idiopathic axonal polyneuropathy: Prevalence of pain and impact on quality of life. CIAP, QoL, VAS
18  2018 Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases. CIDP, LQI, MMN
19  2018 Motor unit number index correlates with disability in Charcot-Marie-Tooth disease. ADM, APB, CMTNSv2, MUNIX, TA
20  2018 Quality of Life in Patients with Gluten Neuropathy: A Case-Controlled Study. GFD, GN, QoL
21  2017 Are electrophysiological features related to disability in patients with anti-MAG neuropathy? anti-MAG, CMAP
22  2017 High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy. ADR, IVIG, MMN, MRC
23  2017 Motor unit number index (MUNIX) in patients with anti-MAG neuropathy. ADM, APB, MAG, MUNIX, RTX, TA
24  2017 Nine-hole Peg Test and Ten-meter Walk Test for Evaluating Functional Loss in Chinese Charcot-Marie-Tooth Disease. 10-MWT, 9HPT, BBS, CMT
25  2017 Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy. MAG, RTX
26  2017 Prevalence, correlates and impact of pain and cramps in anti-MAG neuropathy: a multicentre European study. I-RODS, SF-36 HR-QoL
27  2017 sNCAM as a specific marker of peripheral demyelination. sNCAM
28  2016 Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes. CDAS, CIDP, RODS
29  2016 Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune-mediated neuropathies. CIDP, IVIG, MMN, MRC
30  2016 Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)? ADM, APB, CIDP, ICC, MUNIX, R-ODS, TA
31  2016 Regarding the past, what is the trial you have always been dreaming of in CIDP? ---
32  2016 [Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy]. CIDP
33  2015 Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome. CIK, CR, PBMCs, PD, POEMS, VEGF
34  2015 Critical illness polyneuropathy and myopathy in a rural area in Vietnam. MRC
35  2014 An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. CMT1A, CMTNS, HD
36  2014 Neuromuscular and neuropsychological assessments in survivors of acute respiratory distress syndrome: exploratory comparisons with an at-risk cohort. ARDS
37  2014 [Efficacy of autologous peripheral blood stem cell transplantation (auto-PBSCT) on the neuropathic manifestations in POEMS syndrome]. auto-PBSCT
38  2012 Pain assessment in Charcot-Marie-Tooth (CMT) disease. CMT, CMT1A, CRMD, DETD, HAD, MRC, NPSI, VAS
39  2012 Residual disability 10 years after falling ill in Guillain-Barre syndrome: a prospective follow-up study. EGOS, GBS, SIP
40  2011 Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. MDex
41  2011 Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children. CMT
42  2011 [Improvement of severe and intravenous immunoglobulin-dependent multifocal motor neuropathy with conduction block after long-term rituximab]. IVIG, MMNCB, RTX
43  2010 Characteristics and correlates of sensory function in chronic inflammatory demyelinating polyneuropathy. CIDP, CMAP, MRC, SNAP, SSS
44  2009 Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition? MMNCB, SNAP
45  2007 Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. 9HPT, CMT, MVIC, T10MW
46  2006 A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. ODSS